Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An individualized stemness-related signature to predict prognosis and immunotherapy responses for gastric cancer using single-cell and bulk tissue transcriptomes. | Cancer Med | 2024 | 38168907 | PubTator, text mining | PubMed |
| Activation of ETAR and ETBR in myocardial tissue characterizes heart failure induced by experimental autoimmune myocarditis. | BMC Cardiovasc Disord | 2024 | 38166688 | PubTator, text mining | PubMed |
| Identification of EDNRA as the Key Biomarker for Hypercholesterolemia and Colorectal Cancer. | Tohoku J Exp Med | 2024 | 38123303 | PubTator, text mining | PubMed |
| Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma. | J Cachexia Sarcopenia Muscle | 2024 | 38123146 | PubTator, text mining | PubMed |
| Efficacy and Adverse Effects of Atrasentan in Patients with Diabetic Nephropathy: A Meta-Analysis. | Altern Ther Health Med | 2024 | 37820676 | PubTator, text mining | PubMed |
| Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes. | Transplantation | 2024 | 37527494 | PubTator, text mining | PubMed |
| Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights. | medRxiv | 2024 | 37398174 | PubTator, text mining | PubMed |
| Classical structural identifiability methodology applied to low-dimensional dynamic systems in receptor theory. | J Pharmacokinet Pharmacodyn | 2024 | 37389744 | PubTator, text mining | PubMed |
| Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy. | Front Transplant | 2023 | 38993854 | PubTator, text mining | PubMed |
| Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy. | Front Immunol | 2023 | 38288116 | PubTator, text mining | PubMed |
| A bone to pick-cellular and molecular mechanisms of bone pain in sickle cell disease. | Front Pain Res (Lausanne) | 2023 | 38239327 | PubTator, text mining | PubMed |
| Cadmium-induced Carcinogenesis in Respiratory Organs and the Prostate: Insights from Three Perspectives on Toxicogenomic Approach. | J Cancer Prev | 2023 | 38205367 | PubTator, text mining | PubMed |
| The Role of Cancer Stem Cell Markers in Ovarian Cancer. | Cancers (Basel) | 2023 | 38201468 | PubTator, text mining | PubMed |
| Transcriptional Comparison of Human and Murine Retinal Neovascularization. | Invest Ophthalmol Vis Sci | 2023 | 38153746 | PubTator, text mining | PubMed |
| Practical Considerations for the Use of Sparsentan in the Treatment of Patients with IgAN in Clinical Practice. | Int J Nephrol Renovasc Dis | 2023 | 38149041 | PubTator, text mining | PubMed |
| Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies. | Int J Mol Sci | 2023 | 38139269 | PubTator, text mining | PubMed |
| Genetics in Ischemic Stroke: Current Perspectives and Future Directions. | J Cardiovasc Dev Dis | 2023 | 38132662 | PubTator, text mining | PubMed |
| Proteome Profiling of Brain Vessels in a Mouse Model of Cerebrovascular Pathology. | Biology (Basel) | 2023 | 38132326 | PubTator, text mining | PubMed |
| Understanding the roles of the microbiome in autoimmune rheumatic diseases. | Rheumatol Immunol Res | 2023 | 38125641 | PubTator, text mining | PubMed |
| Clinical-radiological-pathological correlation in pulmonary arterial hypertension. | Eur Respir Rev | 2023 | 38123231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=10